Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 421
Filter
1.
Electron. j. biotechnol ; 52: 30-34, July. 2021. ilus, tab, graf
Article in English | LILACS | ID: biblio-1283487

ABSTRACT

BACKGROUND: This study aimed to develop an amplification method of urea detection based on pHsensitive liposomes. RESULTS: The urease covalently immobilized on the magnetic particles and the pH-sensitive liposomes encapsulating ferricyanide were added to the cyclic-voltammeter cell solution where urea was distributed. The conversion of urea into carbonic acid seemed to induce a pH decrease that caused a reduction in the electrostatic repulsion between the headgroups of weakly acidic 1,2-dipalmitoyl-sn-glycero3-succinate. The reduction induced the liposomes to release potassium ferricyanide that was encapsulated inside. The effects of urea concentration and pH value were investigated. A specific concentration (0.5 mg/mL) of the urea solution was set to observe the response. The activity of urease was reversible with respect to the pH change between 7 and 5. The sensitivity of this detection was almost identical to the comparable techniques such as an enzyme-linked immunosorbent assay and a field-effect transistor. CONCLUSIONS: In summary, the methodology developed in this study was feasible as a portable, rapid, and sensitive method.


Subject(s)
Urea/analysis , Liposomes/chemistry , Urease/chemistry , Enzyme-Linked Immunosorbent Assay , Enzymes, Immobilized , Hydrogen-Ion Concentration
2.
Electron J Biotechnol ; 49: 1-4, Jan. 2021. tab, ilus
Article in Spanish | LILACS | ID: biblio-1291931

ABSTRACT

BACKGROUND: Brucella canis is the etiological agent of canine brucellosis, a worldwide neglected zoonosis that constitutes one of the major infectious causes of infertility and reproductive failure in dogs. Although genomic information available for this pathogen has increased in recent years, here we report the first genome sequencing of a B. canis strain in Chile, and the differences in virulence genes with other B. canis strains. RESULTS: Genome assembly produced a total length of 3,289,216 bp, N50 of 95,163 and GC% of 57.27, organized in 54 contigs in chromosome I, and 21 contigs in chromosome II. The genome annotation identified a total of 1981 CDS, 3 rRNA and 36 tRNA in chromosome I, and 1113 CDS and 10 tRNA in chromosome II. There is little variation between the different strains and the SCL isolate. Phylogenetic analysis showed that the Chilean SCL strain is closely related to B. canis and B. suis strains. Small differences were found when compared to the Serbian isolate, but all strains shared the same recent common ancestor. Finally, changes in the sequence of some virulence factors showed that the SCL strain is similar to other South American B. canis strains. CONCLUSIONS: This work sequenced and characterized the complete genome of B. canis strain SCL, evidencing the complete presence of all the genes of the virB operon, and minor changes in outer membrane proteins and in the urease operon. Our data suggest that B. canis was introduced from North America and then spread throughout the South American continent.


Subject(s)
Animals , Dogs , Brucellosis/epidemiology , Brucella canis/genetics , Brucella canis/pathogenicity , Urease/genetics , Brucellosis/transmission , Zoonoses , Chile , Genome
3.
Arq. ciências saúde UNIPAR ; 24(1): 3-7, jan-abr. 2020.
Article in Portuguese | LILACS | ID: biblio-1095737

ABSTRACT

Criptococose é uma doença grave que afeta tanto imunocomprometidos quanto imunocompetentes, com isso analisar a virulência é fundamental para novas terapêuticas. Objetivo: Analisar a capacidade de virulência e susceptibilidade aos antifúngicos de Cryptococcus spp. isolados de líquor de pacientes de hospital do norte do Paraná. Métodos: A partir de dois isolados clínicos C. neoformans e C. gattii, realizou-se a confirmação da identificação. Para a virulência, avaliou-se o tamanho da cápsula, capacidade de sobrevivência após exposição a neutrófilos, produção de melanina e urease. No antifungigrama por difusão em disco utilizou-se: anfotericina B, cetoconazol, voriconazol, itraconazol e miconazol. Resultados: C. gattii destaca-se por maior desenvolvimento da cápsula além da melhor capacidade de sobreviver a fagocitose em relação ao C. neoformans. No antifungigrama, ambos os isolados se apresentam sensíveis às drogas estudadas. Conclusão: Esses achados contribuem para a compreensão das diferentes patogêneses entre C. gattii e C. neoformans.


Cryptococcosis is a serious disease that can affect both immunocompromised and immunocompetent individuals, thus the virulence analysis is fundamental for the development of new treatments. Objective: To analyze the virulence and susceptibility of Cryptococcus spp. isolated from cerebrospinal fluid of patients from a hospital in the north of Paraná. Methods: From two clinical isolates, C. neoformans and C. gattii were confirmed and identified. For virulence, capsule size, survival capacity after exposure to neutrophils, melanin production and urease were evaluated. In the disc-diffusion method, the following antifungals were used: amphotericin B, ketoconazole, voriconazole, itraconazole and miconazole Results: It was observed that C. gattii presents greater results for development of the capsule beside presenting the best ability to survive phagocytosis in relation to C. neoformans. In the disc-diffusion method, both isolates presented sensitivity to the studied drugs. Conclusion: These findings contribute to the understanding of the different pathogens between C. gattii and C. neoformans.


Subject(s)
Cryptococcosis/virology , Virulence Factors/analysis , Antifungal Agents/analysis , Phagocytosis , Urease/urine , Yeasts/virology , Capsules/analysis , Pharmaceutical Preparations , Amphotericin B/analysis , Itraconazole , Cryptococcus neoformans/virology , Agar/analysis , Cryptococcus gattii/virology , Voriconazole , Melanins/analysis , Miconazole , Neutrophils/virology
4.
Arq. gastroenterol ; 56(3): 264-269, July-Sept. 2019. tab, graf
Article in English | LILACS | ID: biblio-1038716

ABSTRACT

ABSTRACT BACKGROUND: It is widely assumed that gender, age, gastritis and Helicobacter pylori , all have some degree of correlation and, therefore, can synergistically lead to the development of gastric cancer. OBJECTIVE: In this cross-sectional study, we expected to observe the above mentioned correlation in the analysis of medical records of 67 patients of both sexes (female, n=44), mean age ± standard deviation: 41±12 years old, all from Belém (capital of Pará State, Brazilian Amazon), a city historically known as one with the highest gastric cancer prevalence in this country. METHODS: All patients were submitted to upper gastrointestinal endoscopy for gastric biopsy histopathological analysis and rapid urease test. All diagnoses of gastritis were recorded considering its topography, category and the degree of inflammatory activity, being associated or not associated with H. pylori infection. RESULTS: The results show that no statistically relevant associations were found among the prevalences of the observed variables. CONCLUSION: The authors hypothesize that observed risk factors associated to gastric cancer might be lesser synergistic than is usually expected.


RESUMO CONTEXTO: É amplamente assumido que gênero, idade, gastrite e Helicobacter pylori , todos têm algum grau de correlação e, portanto, podem sinergicamente levar ao desenvolvimento de câncer gástrico. OBJETIVO: Neste estudo transversal, esperamos observar a correlação acima mencionada na análise de prontuários de 67 pacientes de ambos os sexos (sexo feminino, n=44), média de idade ± desvio padrão: 41±12 anos, todos de Belém (capital do Estado do Pará, Amazônia Brasileira), uma cidade historicamente conhecida como sendo uma das que apresenta maior prevalência de câncer gástrico no país. MÉTODOS: Todos os pacientes foram submetidos à endoscopia digestiva alta para análise histopatológica da biópsia gástrica e teste rápido da urease. Todos os diagnósticos de gastrite foram registrados considerando sua topografia, categoria e grau de atividade inflamatória, sendo associada ou não associada à infecção por H. pylori . RESULTADOS: Os resultados mostram que não foram encontradas associações estatisticamente relevantes entre as prevalências das variáveis observadas. CONCLUSÃO: Os autores levantam a hipótese de que os fatores de risco associados ao câncer gástrico podem ser menos sinérgicos do que o esperado.


Subject(s)
Humans , Male , Female , Adult , Stomach Neoplasms/microbiology , Urease/analysis , Helicobacter Infections/complications , Gastric Mucosa/microbiology , Gastric Mucosa/pathology , Stomach Neoplasms/pathology , Stomach Neoplasms/epidemiology , Biopsy , Brazil/epidemiology , Sex Factors , Prevalence , Cross-Sectional Studies , Endoscopy, Digestive System , Helicobacter pylori , Helicobacter Infections/enzymology , Helicobacter Infections/epidemiology , Age Factors , Sex Distribution , Gastritis/microbiology , Gastritis/pathology , Intestinal Mucosa/enzymology , Middle Aged
5.
Article in English | WPRIM | ID: wpr-719438

ABSTRACT

BACKGROUND/AIMS: Both bismuth-containing quadruple therapy and moxifloxacin-containing triple therapy have been suggested as second-line eradication therapy for Helicobacter pylori (H. pylori) infection. We aimed to evaluate the efficacy of 14-day moxifloxacin-containing triple therapy (14-EAM) in second-line H. pylori eradication in comparison to 7-day bismuth-containing quadruple therapy (7-RBMT). METHODS: From January 2011 to December 2015, a total of 569 patients who failed to respond to first-line triple therapy and who subsequently received second-line 7-RBMT or 14-EAM were retrospectively enrolled. The eradication rates were identified using per-protocol (PP) analysis. H. pylori eradication was confirmed by a 13C-urea breath test (UBiT-IR300®; Otsuka Electronics, Co., Ltd., Osaka, Japan) or a rapid urease test (CLOtest®; Delta West, Bentley, Australia) at least 4 weeks after completion of eradication therapy. RESULTS: A total of 487 and 82 patients received 7-RBMT and 14-EAM, respectively. PP eradication rates were 93.6% (366/391; 95% CI, 91.0–95.9%) with 7-RBMT and 73.8% (48/65; 95% CI, 63.1–84.6%) with14-EAM (p < 0.001). Therefore, the eradication rates with 7-RBMT were significantly higher than with 14-EAM according to the PP analysis. The adverse event rate was 17.1% (67/391) with 7-RBMT and 7.7% (5/65) with 14-EAM (p=0.065). In terms of risk factors, multivariate analysis revealed that 14-EAM (OR, 5.47; 95% CI, 2.74–10.93) was related to H. pylori eradication failure. CONCLUSIONS: 7-RBMT may be an effective second-line therapy in patients who failed to respond to first-line triple therapy in Korea, where there is a high prevalence of H. pylori infection.


Subject(s)
Bismuth , Breath Tests , Disease Eradication , Helicobacter pylori , Helicobacter , Humans , Korea , Multivariate Analysis , Prevalence , Retrospective Studies , Risk Factors , Urease
6.
Article in English | WPRIM | ID: wpr-761881

ABSTRACT

PURPOSE: Because of the inconsistent symptoms associated with Ureaplasma infections, their clinical significances in genitourinary tracts are under debate. Therefore, we evaluated the presence of Ureaplasma urealyticum (UU) and Ureaplasma parvum (UP) in urine samples and examined their associations with chronic prostatitis (CP) through a case and control study. MATERIALS AND METHODS: We included 696 nonchlamydial nongonococcal (NCNG) urine samples from men; 350 were categorized into non-inflammatory CP, 88 in inflammatory CP, and 258 in non-CP group. We amplified a region in the Ureaplasma urease areas from these samples and determined their biovars using the Sanger method. RESULTS: Among the NCNG population, the rates of UU, UP, and non-UU/UP were 3.88%, 6.46%, and 89.66%, respectively. The overall infection rates of non-CP, inflammatory CP, and non-inflammatory CP groups were 4.15%, 6.10%, and 3.65% in UU (p=0.612) and 6.85%, 7.22%, and 6.50% in UP (p=0.968), respectively. UU infection increased the risk of white blood cell (WBC) counts (≥5) in urine (p=0.005). In contrast, UP infections did not increase the risks of urethritis. Re-analysis from the 633 men who were excluded from urethritis effects did not reveal the associations between UU infection and the clinical characteristics of CP. Furthermore, the profiles from the National Institutes of Health-Chronic Prostatitis Symptom Index questionnaire and WBC counts in expressed prostatic secretion were similar among the non-CP and the two CP groups in each Ureaplasma infection. CONCLUSIONS: We found that UU may induce male urethritis. However, Ureapalsma species in urine were not definitively associated with the occurrence of CP.


Subject(s)
Academies and Institutes , Case-Control Studies , Humans , Leukocytes , Male , Methods , Prostate , Prostatitis , Ureaplasma Infections , Ureaplasma urealyticum , Ureaplasma , Urease , Urethritis
7.
Article in Korean | WPRIM | ID: wpr-742135

ABSTRACT

BACKGROUND/AIMS: The Helicobacter pylori (H. pylori) eradication rate of standard triple therapy is unsatisfactory in Korea, and sequential therapy (SQT) has been suggested to be a practical first-line alternative regimen. The aim of this prospective study was to document changes in annual eradication rates of SQT. METHODS: A total of 983 H. pylori-positive subjects were enrolled from 2010 to 2018 and their data were subjected to intention-to-treat (ITT) and per-protocol (PP) analysis. All subjects received 10-day sequential therapy consisting of 40 mg esomeprazole and 1 g amoxicillin b.i.d for 5 days followed by 40 mg esomeprazole b.i.d, 500 mg clarithromycin b.i.d and 500 mg metronidazole t.i.d for 5 days. The 13C-urea breath test, rapid urease test (CLO test®), and histology were used to confirm eradication. Compliance and side effects were also investigated. RESULTS: ITT and PP eradication rates of SQT were 69.9% (687 of 983) and 87.1% (657 of 754), respectively. The annual eradication rate of ITT remained consistent over the 8-year study period (p for trend=0.167), whereas PP analysis showed the eradication rate increased (p for trend=0.042). The overall adverse event rate for SQT was 41.7% (410 subjects). CONCLUSIONS: Despite high antibiotic resistance rates in Korea, the eradication rate of SQT did not decrease over the 8-year study period.


Subject(s)
Amoxicillin , Breath Tests , Clarithromycin , Compliance , Drug Resistance, Microbial , Esomeprazole , Helicobacter pylori , Helicobacter , Intention to Treat Analysis , Korea , Metronidazole , Prospective Studies , Urease
8.
Article in Korean | WPRIM | ID: wpr-761575

ABSTRACT

BACKGROUND/AIMS: The incidence of gastric cancer (GC) in Korea is very high compared to that in other countries. The aim of this study was to investigate the trends of GC in patients for over 16 years. MATERIALS AND METHODS: A total of 1,227 patients with GC were prospectively enrolled at Seoul National University Bundang Hospital between 2003 and 2018. Age, sex, histologic type (Lauren classification), and Helicobacter pylori (H. pylori) infection status were compared between three periods (2003~2007, 2008~2012, and 2013~2018). H. pylori infection status was evaluated based on histology, rapid urease test, culture, serology, and history of H. pylori eradication. Patients with severe atrophy or intestinal metaplasia based on histology were assumed to have previous H. pylori infection. RESULTS: Most patients with GC underwent endoscopic mucosal resection/endoscopic submucosal dissection or another type of surgery. Early GC (EGC) and advanced GC (AGC) were detected in 769 (62.7%) and 458 (37.3%) patients, respectively, and intestinal and diffuse types were detected in 714 (58.2%) and 485 (39.5%) patients, respectively. The prevalence of EGC increased from 54.0% (252/467) to 63.5% (359/565) to 81.0% (158/195) in 2003~2007, 2008~2012, and 2013~2018, respectively. The prevalence of H. pylori-positive GC decreased from 93.4% (436/467) to 88.5% (500/565) to 82.1% (160/195) during these three periods, respectively (P<0.001). Multivariate logistic analysis showed that diffuse-type GC was continuously more prevalent in those who were younger than 50 years, who were female, and who harbored the predominant AGC type. CONCLUSIONS: Over 16 years, the prevalence of EGC increased with a decrease in H. pylori infection rate. Diffuse-type GC was continuously more common in young and female patients.


Subject(s)
Atrophy , Female , Helicobacter pylori , Humans , Incidence , Korea , Metaplasia , Prevalence , Prospective Studies , Seoul , Stomach Neoplasms , Urease
9.
Chinese Journal of Biotechnology ; (12): 204-215, 2019.
Article in Chinese | WPRIM | ID: wpr-771386

ABSTRACT

Urease decomposes urea to ammonia, and has application potential in agriculture and medical treatment. Urease proteins include structural proteins (UreA, UreB and UreC) and accessory proteins (UreD/UreH, UreE, UreF and UreG), each of them has its own unique role in urease maturation. The structural proteins form the active center of urease, and the accessory proteins are responsible for the delivery of nickel. We review here the structure and function of bacterial urease complexes, and how each protein interacts to complete the activation process. We hope to provide theoretical basis for the regulation of urease activity and the development of urease inhibitors.


Subject(s)
Bacterial Proteins , Nickel , Urease , Metabolism
10.
Chinese Journal of Biotechnology ; (12): 567-576, 2019.
Article in Chinese | WPRIM | ID: wpr-771352

ABSTRACT

Ethyl carbamate (EC), a carcinogenic and teratogenic chemical that is widely distributed in various alcoholic beverages, has attracted much attention. Microbial enzymatic degradation of EC in rice wine is always efficient and attractive. In this review, we summarize the research progress and problems of microbial enzymatic elimination of EC in rice wine from three aspects: the mechanisms of EC formation in rice wine, the research progress of acid urease, and the research progress of urethanase. Then, we propose the corresponding strategies to solve the problems: screening new urethanase with satisfied enzyme properties, food-grade expression and directed evolution of the bifunctional Fe³⁺-dependent acid urease and acid urease used in combination with urethanase to eliminate both urea and EC in rice wine.


Subject(s)
Oryza , Urea , Urease , Urethane , Wine
11.
Article in Korean | WPRIM | ID: wpr-713778

ABSTRACT

BACKGROUND/AIMS: Several previous studies suggest that eradication of Helicobacter pylori (H. pylori) leads to the disappearance of gastric hyperplastic polyps. However, little is known about the effect of H. pylori status and eradication on the recurrence of gastric polyps after endoscopic removal. Here, we investigated the recurrence of gastric polyps according to the final H. pylori status in patients who underwent endoscopic removal of gastric hyperplastic polyps. METHODS: Between January 2011 and December 2016, patients who underwent endoscopic removal of gastric hyperplastic polyps and were followed-up for more than two months were enrolled. The success of H. pylori eradication was assessed by histology and rapid urease test or urea breath test, at least 4 weeks after the completion of eradication treatment. At follow-up, the recurrence of gastric polyp was evaluated via esophagogastroduodenoscopy. RESULTS: Seventy-nine patients were enrolled. During the mean follow-up period of 16.4 months, the recurrence rate of gastric polyp was 25.3%. Among those who received H. pylori eradication therapy, the H. pylori persistent group showed a higher recurrence of polyp than the H. pylori eradicated group; but there was no statistical significance (42.9% vs. 21.7%, p=0.269). Regarding the final H. pylori infection status, the recurrence rate of gastric polyps was significantly higher in the H. pylori positive group than in the H. pylori negative group (42.9% vs. 18.9%, p=0.031). In multivariate analysis, the final H. pylori infection status was a significant risk factor for gastric polyp recurrence after endoscopic removal. CONCLUSIONS: The final positive H. pylori infection status is significantly associated with higher recurrence of gastric hyperplastic polyps after endoscopic removal.


Subject(s)
Breath Tests , Endoscopy, Digestive System , Follow-Up Studies , Helicobacter pylori , Helicobacter , Humans , Multivariate Analysis , Polyps , Recurrence , Risk Factors , Stomach Neoplasms , Urea , Urease
12.
Article in English | WPRIM | ID: wpr-713263

ABSTRACT

Helicobacter pylori (H. pylori), a causative agent of chronic gastritis and gastric cancer, has several virulent factors for own survival and progression toward gastric diseases in human stomach. Of those, H. pylori produces mainly urease (10~15% total protein weight) that neutralize the gastric acid for survival. Here, we identified the antigenic epitope of urease and then developed an ELISA using the antigen including the epitope of urease. We identified the antigenic epitope of urease that induces IgA antibodies in human using truncated mutants. Eight kinds of serially-truncated mutant of UreA and UreB were prepared and subjected to immunoblot using pooled sera of patients with gastric disorders. UreBEnd protein containing UreB epitope was produced and investigated its diagnostic value via ELISA in children. As a result, mutants having last 24 amino acid residues of UreB carboxyl terminus deleted did not show IgA-reactive band. The clones that contained the downstream of 448(th) amino acid in UreB showed IgA-reactive band. The serodiagnostic value of the UreBEnd recombinant protein including identified epitope was confirmed via IgA ELISA and shown to have 97% sensitivity and 100% specificity. These results demonstrated that carboxyl terminal region of UreB carries an antigenic epitope for IgA response in human. It may be useful for detecting H. pylori infection with improved test accuracy and minimum use of endoscopy.


Subject(s)
Antibodies , Child , Clone Cells , Endoscopy , Enzyme-Linked Immunosorbent Assay , Epitopes , Gastric Acid , Gastritis , Helicobacter pylori , Helicobacter , Humans , Immunoglobulin A , Sensitivity and Specificity , Stomach , Stomach Diseases , Stomach Neoplasms , Urea , Urease
13.
Laboratory Animal Research ; : 216-222, 2018.
Article in English | WPRIM | ID: wpr-718846

ABSTRACT

The efficacy of standard therapeutic strategies for Helicobacter pylori (H. pylori) infection is decreasing over time due to the emergence of drug-resistant strains. As an alternative, the present study investigated the capacity of Lactobacilllus paracasei (L. paracasei) HP7, isolated from kimchi, to inhibit H. pylori growth. The effects of L. paracasei HP7 on H. pylori adhesion and H. pylori-induced inflammation were examined in AGS human gastric adenocarcinoma epithelial cells and a mouse model of H. pylori SS1 infection. L. paracasei HP7 reduced H. pylori adhesion to AGS cells and suppressed the inflammatory response in infected cells by downregulating interleukin-8. H. pylori colonization in the stomach of C57BL/6 mice was demonstrated by rapid urease test, and results showed significant decrease in mice post-treated with L. paracasei HP7. Additionally, L. paracasei HP7 decreased gastric inflammation and epithelial lesions in the stomach of H. pylori-infected mice. These results demonstrate that L. paracasei HP7 treatment can inhibit H. pylori growth and is thus a promising treatment for patients with gastric symptoms such as gastritis that are caused by H. pylori infection.


Subject(s)
Adenocarcinoma , Animals , Colon , Epithelial Cells , Gastritis , Helicobacter pylori , Helicobacter , Humans , In Vitro Techniques , Inflammation , Interleukin-8 , Mice , Stomach , Urease
14.
Article in Korean | WPRIM | ID: wpr-718003

ABSTRACT

Accurate diagnosis of Helicobacter pylori (H. pylori) infection is mandatory for the effective management of many gastroduodenal diseases. Currently, various diagnostic methods are available for detecting these infections, and the choice of method should take into account the clinical condition, accessibility, advantage, disadvantage, as well as cost-effectiveness. The diagnostic methods are divided into invasive (endoscopic-based) and non-invasive methods. Non-invasive methods included urea breath test, stool antigen test, serology, and molecular methods. Invasive methods included endoscopic imaging, rapid urease test, histology, culture, and molecular methods. In this article, we provide a review of the currently available options and recent advances of various diagnostic methods.


Subject(s)
Breath Tests , Diagnosis , Helicobacter pylori , Helicobacter , Methods , Urea , Urease
15.
Yonsei Medical Journal ; : 633-642, 2018.
Article in English | WPRIM | ID: wpr-715899

ABSTRACT

PURPOSE: To investigate the effects of Helicobacter pylori (H. pylori)-CagA and the urease metabolite NH₄⁺ on mucin expression in AGS cells. MATERIALS AND METHODS: AGS cells were transfected with CagA and/or treated with different concentrations of NH₄⁺CL. Mucin gene and protein expression was assessed by qPCR and immunofluorescence assays, respectively. RESULTS: CagA significantly upregulated MUC5AC, MUC2, and MUC5B expression in AGS cells, but did not affect E-cadherin and MUC6 expression. MUC5AC, MUC6, and MUC2 expression in AGS cells increased with increasing NH₄⁺ concentrations until reaching a peak level at 15 mM. MUC5B mRNA expression in AGS cells (NH₄⁺ concentration of 15 mM) was significantly higher than that at 0, 5, and 10 mM NH₄⁺. No changes in E-cadherin expression in AGS cells treated with NH₄⁺ were noted, except at 20 mM. The expression of MUC5AC, MUC2, and MUC6 mRNA in CagA-transfected AGS cells at an NH₄⁺ concentration of 15 mM was significantly NH₄⁺ concentration, and was significantly higher compared to that in untreated cells. No significant change in the expression of E-cadherin mRNA in CagA-transfected AGS cells was observed. Immunofluorescence assays confirmed the observed changes. CONCLUSION: H. pylori may affect the expression of MUC5AC, MUC2, MUC5B, and MUC6 in AGS cells via CagA and/or NH₄⁺, but not E-cadherin.


Subject(s)
Ammonium Chloride , Ammonium Compounds , Cadherins , Fluorescent Antibody Technique , Helicobacter pylori , Helicobacter , Mucins , RNA, Messenger , Stomach , Urease , Virulence
16.
Article in English | WPRIM | ID: wpr-715044

ABSTRACT

Allium hookeri is widely consumed plant as a vegetable and herbal medicine in southeastern Asia. Allium hookeri has been reported antioxidant, improvement of bone health and antidiabetic effects. In the present study, we investigated the potential inhibitory effect of Allium hookeri extract (AHE) on Helicobacter pylori. The in vitro anti-bacterial activities of AHE were determined by disk agar diffusion method. Also, the inhibition effect of the AHE on H. pylori infection was investigated using a mouse model. H. pylori colonization was confirmed by rapid urease tests, as described previously. Mucosal damage was evaluated grossly and histologically according to previously described criteria. As the results of the disk agar diffusion assay, CLR, AMX and MTZ inhibited the bacterial growth with inhibition zone of 19.2, 15.2 and 7.5 mm, respectively. AHE 100 µg/mL showed an inhibition zone value of 20.6 mm. Rapid urease tests of the mice stomachs demonstrated a significant reduction in H. pylori colonization. In addition to the therapeutic effect against H. pylori infection, the AHE reduced mucosal inflammation and epithelial damages in the stomach of H. pylori-infected mice. These results demonstrate that the AHE successfully cured an H. pylori infection and treated the H. pylori infection. This AHE could be a promising treatment for patients with gastric complaints including gastritis caused by H. pylori.


Subject(s)
Agar , Allium , Animals , Asia, Southeastern , Colon , Diffusion , Gastritis , Helicobacter , Helicobacter pylori , Herbal Medicine , Humans , In Vitro Techniques , Inflammation , Methods , Mice , Plants , Stomach , Urease , Vegetables
17.
Article in English | WPRIM | ID: wpr-738963

ABSTRACT

BACKGROUND/AIMS: The current standard regimen for the treatment of Helicobacter pylori infection is a combination of a proton pump inhibitor (PPI), amoxicillin, and clarithromycin. The aim of this study was to determine the effectiveness of PPIs taken separately before a meal for the treatment of H. pylori infection. MATERIALS AND METHODS: This retrospective study included 160 patients who were tested positive for rapid urease in Kosin Unversity Gospel Hospital between January 2008 and December 2012. The patients were divided into two groups (n=80 in each group) based on the method of administration of the H. pylori triple therapy. Group A took a PPI before a meal and amoxicillin and clarithromycin after a meal. Group B took all three medications together after a meal. The 13C-urea breath test was performed after 4 weeks to assess the eradication of H. pylori. RESULTS: H. pylori was eradicated in 58/80 (72.5%) patients in group A and 60/80 (75.0%) patients in group B, with no significant difference between the groups (P=0.719). Adverse effects occurred in 4 patients of group A and 7 patients of group B (5.0% and 8.8%, respectively); however, the difference between the groups was not significant (P=0.232). CONCLUSIONS: Administration of all medicines at once after a meal may be the better prescription for treatment, considering patient convenience and improved likelihood of compliance.


Subject(s)
Amoxicillin , Breath Tests , Clarithromycin , Compliance , Helicobacter pylori , Helicobacter , Humans , Meals , Methods , Prescriptions , Proton Pump Inhibitors , Proton Pumps , Protons , Retrospective Studies , Urease
18.
GED gastroenterol. endosc. dig ; 36(1): 1-6, jan.-mar. 2017. ilus, tab
Article in Portuguese | LILACS | ID: biblio-833536

ABSTRACT

Introdução: o Helicobacter pylori (H. pylori) é uma bactéria gram-negativa capaz de colonizar a mucosa gástrica e predispor a diversas patologias. Para identificação do H. pylori, os testes invasivos ainda são os mais realizados, sendo que não há um teste padrão ouro aceito universalmente. A análise histológica e o teste da urease são dois dos principais métodos diagnósticos utilizados atualmente. Objetivo: o presente estudo tem como objetivo avaliar a positividade do teste da urease e da análise histopatológica, levando em consideração as variáveis como sexo, idade e patologias associadas. Métodos: trata-se de um estudo transversal de caráter quantitativo, tendo como base dados obtidos por meio de laudos de endoscopias realizadas no Hospital Universitário Santa Terezinha de Joaçaba ­ SC no período entre abril de 2014 e dezembro de 2015, assim como a partir de dados dos exames anatomopatológicos dos respectivos casos, fornecidos pelo Instituto de Patologia Joaçaba, de Joaçaba ­ SC. Os dados foram analisados e comparados através do software Microsoft Office Excel. Resultados: dos 313 pacientes que compunham a pesquisa, o teste da urease mostrou-se positivo para o H. pylori em 84 (26,83%) amostras e a avaliação histopatológica em 89 (28,43%) amostras. Em relação ao sexo, o teste da urease apresentou maior prevalência de casos positivos em homens, com 45 (53,57%) amostras. Já a histopatologia mostrou leve predominância de mulheres, com 45 (50,57%) amostras. No tocante à idade dos pacientes, ambos os métodos diagnósticos apresentaram maior frequência de positividade entre 41 e 50 anos e entre 61 e 70 anos. Quanto às lesões gástricas encontradas em pacientes com H. pylori positivo, no teste da urease, 54,76% das amostras apresentavam pangastrite enantematosa e, na avaliação histopatológica, 87,64% dos pacientes apresentavam gastrite crônica ativa. Conclusão: a comparação entre os dois métodos diagnósticos, teste da urease e histopatologia mostrou resultados equivalentes na detecção do H. pylori, sendo indicada a realização dos métodos concomitantemente. A gastrite foi a patologia mais evidenciada em ambos os métodos com H. pylori positivo; no entanto, muitos dos não acometidos também apresentavam tal patologia, o que sugere a presença de outros fatores envolvidos na gênese da afecção.


Introduction: Helicobacter pylori (H. pylori) is a gram negative bacteria capable of colonizing the gastric mucosa and predispose to various diseases. For identification of H. pylori, invasive tests are still the most accomplished, and there is no gold standard universally accepted. Histological analysis and urease test are two of the main diagnostic methods currently used. Aims: this study aims to evaluate the test positive urease and histopathology, taking into account variables such as gender, age and associated pathologies. Methods: this is a cross-sectional study of quantitative approach, based on data obtained through endoscopies reports conducted at the University Hospital Santa Terezinha de Joaçaba - SC from April 2014 to December 2015, as well as from data pathological examination of their cases, provided by the Institute of Pathology Joaçaba, Joaçaba - SC. The data were analyzed and compared using the Microsoft Office Excel software. Results: of the 313 patients who comprised the study, the urease test positive proved to H. pylori in 84 (26.83%) samples and histopathological evaluation in 89 (28.43%) samples. Regarding gender, the urease test showed a higher prevalence of positive cases in men, with 45 (53.57%) samples. Already histopathology showed slight predominance of women with 45 (50.57%) samples. Regarding the age of the patients, both diagnostic methods showed a higher frequency of positivity between 41 and 50 years and between 61 and 70 years. As for gastric lesions found in patients with H. pylori positive, the urease test, 54.76% of the samples had enanthematous pangastritis, and in histopathology, 87.64% of patients had chronic active gastritis. Conclusion: the comparison between the two diagnostic methods, urease test and histopathology showed equivalent results in the detection of H. pylori is indicated performing the methods concurrently. Gastritis was more evident pathology in both methods with H. pylori positive, however, many unaffected also had such pathology, suggesting the presence of other factors involved in the pathogenesis of the disease.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Urease , Endoscopy, Digestive System , Helicobacter pylori , Helicobacter Infections , Helicobacter Infections/diagnosis , Gastric Mucosa/pathology , Cross-Sectional Studies
19.
Electron. j. biotechnol ; 25: 75-83, ene. 2017. tab, graf, ilus
Article in English | LILACS | ID: biblio-1008594

ABSTRACT

Background: Helicobacter pylori is considered as the main risk factor in the development of gastric cancer. In the present study, we performed a detailed characterization of the probiotic properties and the anti-H. pylori activity of a previously isolated lactobacillus strain ­ Lactobacillus fermentum UCO-979C ­ obtained from human gut. Results: The strain tolerated pH 3.0; grew in the presence of 2% bile salts; produced lactic acid and hydrogen peroxide; aggregated in saline solution; showed high hydrophobicity; showed high adherence to glass; Caco-2 and gastric adenocarcinoma human cells (AGS) cells; showed an efficient colonization in Mongolian Gerbils; and potently inhibited the growth and urease activity of H. pylori strains. L. fermentum UCO-979C significantly inhibited H. pylori-induced IL-8 production in AGS cells and reduced the viability of H. pylori. With regard to innocuousness, the strain UCO-979C was susceptible to several antibiotics and did not produce histamine or beta-haemolysis in blood agar containing red blood cells from various origins. Conclusion: The results demonstrated that L. fermentum UCO-979C is a very good candidate as a probiotic for the protection of humans against H. pylori infections.


Subject(s)
Humans , Animals , Helicobacter pylori/drug effects , Helicobacter Infections/prevention & control , Probiotics/pharmacology , Lactobacillus fermentum/physiology , Anti-Bacterial Agents/pharmacology , Stomach Neoplasms/prevention & control , Urease/antagonists & inhibitors , Interleukin-8/antagonists & inhibitors , Gerbillinae , Disease Models, Animal , Hydrophobic and Hydrophilic Interactions
20.
Gut and Liver ; : 612-619, 2017.
Article in English | WPRIM | ID: wpr-140059

ABSTRACT

BACKGROUND/AIMS: Atrophic gastritis is considered a premalignant lesion. We aimed to evaluate the risk factors for gastric tumorigenesis in underlying mucosal atrophy. METHODS: A total of 10,185 subjects who underwent upper gastrointestinal endoscopy between 2003 and 2004 were enrolled in this retrospective cohort study. Follow-up endoscopy was performed between 2005 and 2014. Atrophic gastritis and intestinal metaplasia were assessed by endoscopy using the Kimura-Takemoto classification. Helicobacter pylori infection was evaluated based on serum immunoglobulin G antibody levels, the rapid urease test, or the urea breath test. RESULTS: Atrophic gastritis was confirmed in 3,714 patients at baseline; 2,144 patients were followed up for 6.9 years, and 1,138 exhibited increased atrophy. A total of 69 subjects were diagnosed with gastric neoplasm during follow-up (35 adenoma and 34 carcinoma). Age ≥55 years (hazard ratio [HR], 1.234), alcohol consumption (HR, 1.001), and H. pylori infection (HR, 1.580) were associated with increased mucosal atrophy. The risk factors for gastric neoplasm in underlying mucosal atrophy were age ≥55 years (HR, 2.582), alcohol consumption (HR, 1.003), extent of mucosal atrophy (HR, 2.285 in C3-O1; HR, 4.187 in O2–O3), and intestinal metaplasia (HR, 2.655). CONCLUSIONS: Extent of atrophy, intestinal metaplasia, and alcohol consumption are significant risk factors for gastric neoplasm in underlying mucosal atrophy.


Subject(s)
Adenoma , Alcohol Drinking , Atrophy , Breath Tests , Carcinogenesis , Classification , Cohort Studies , Endoscopy , Endoscopy, Gastrointestinal , Epidemiology , Follow-Up Studies , Gastritis, Atrophic , Helicobacter pylori , Humans , Immunoglobulin G , Metaplasia , Retrospective Studies , Risk Factors , Stomach , Stomach Neoplasms , Urea , Urease
SELECTION OF CITATIONS
SEARCH DETAIL